Samuel had totally lost his speech, but now he started with mono-syllables as YES-NO and today he can pronounce longer words like MOM AND DAD.
Lady Liana Sierra (Colombia)
He had never shown an improvement like now
Ana Lucia Patiño (Colombia)
NeuroAiD managed to make him independent
María Teresa Serna (Colombia)
The NeuroAiD treatment has been very beneficial for my improvement
We started the treatment on 26th November 2010 following the recommended dosage. We started to notice some positive improvements. although there were not very significant at the beginning. They started to accentuate more throughout the treatment: the spasticity was reduced, the sense of orientation increased as well as speaking and movement capability at the end of the first month of treatment.
Liliana Castaño Muñoz (Colombia)
I took the treatment for three months which enabled me to partially move again my left wrist which was completely paralysed….What I can tell is that NeuroAiD had no side effects or interaction with the drugs I was taking: anticoagulant, anticonvulsion, antidepressant, and a few others
Olga Lucia Giorgi Gutierrez (Colombia)
After one and a half month of treatment taken in a regular dosage, we had already noticed the changes: almost complete recovery of the sensibility, the improvement of the perception, the concentration, the balance and the walking is now very fluid. She rarely uses her walking stick, not only because her muscles strengthened but also because her spasticity decreased.
Melissa Ortiz Lopez (Colombia)
Information for Medical Professionals
Learn key facts about NeuroAiD and assess how it can be relevant in your clinical practices
NeuroAiD™ is a trademark of Moleac. MLC601 (NeuroAiD™) and MLC901 (NeuroAiD™II / NurAiD™II) are 2 different proprietary formulae which have been shown to be equivalent in pharmacology and are referred as «NeuroAiD» on this page, except in case of specific mentions.